141 related articles for article (PubMed ID: 2470738)
21. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
Bakker AH; Nieuwenbroek NM; Verheijen JH
Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
[TBL] [Abstract][Full Text] [Related]
22. The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.
Cassels R; Fears R; Smith RA
Biochem J; 1987 Oct; 247(2):395-400. PubMed ID: 3122725
[TBL] [Abstract][Full Text] [Related]
23. Kinetic studies of plasminogen activation by epithelial tissue plasminogen activator.
Electricwala A; Ling RJ; Atkinson T
Blood Coagul Fibrinolysis; 1990; 1(1):31-9. PubMed ID: 2129390
[TBL] [Abstract][Full Text] [Related]
24. Identification of a site in fibrin(ogen) which is involved in the acceleration of plasminogen activation by tissue-type plasminogen activator.
Nieuwenhuizen W; Vermond A; Voskuilen M; Traas DW; Verheijen JH
Biochim Biophys Acta; 1983 Oct; 748(1):86-92. PubMed ID: 6684481
[TBL] [Abstract][Full Text] [Related]
25. The influence of fibrin(ogen) fragments on the kinetic parameters of the tissue-type plasminogen-activator-mediated activation of different forms of plasminogen.
Nieuwenhuizen W; Voskuilen M; Vermond A; Hoegee-de Nobel B; Traas DW
Eur J Biochem; 1988 May; 174(1):163-9. PubMed ID: 3131143
[TBL] [Abstract][Full Text] [Related]
26. Characterization of functional domains in human tissue-type plasminogen activator with the use of monoclonal antibodies.
Holvoet P; Lijnen HR; Collen D
Eur J Biochem; 1986 Jul; 158(1):173-7. PubMed ID: 3089776
[TBL] [Abstract][Full Text] [Related]
27. Spatial orientation of tissue-type plasminogen activator bound at the melanoma cell surface.
Bizik J; Trancikova D; Felnerova D; Verheijen JH; Vaheri A
Biochem Biophys Res Commun; 1997 Oct; 239(1):322-8. PubMed ID: 9345318
[TBL] [Abstract][Full Text] [Related]
28. Fibrin-mediated plasminogen activation.
Nieuwenhuizen W
Ann N Y Acad Sci; 2001; 936():237-46. PubMed ID: 11460481
[TBL] [Abstract][Full Text] [Related]
29. Binding of tissue plasminogen activator to endothelial cells. The effect on functional properties. Localization of a ligand in the B-chain of tPA.
Cheng XF; Brohlin M; Pohl G; Bäck O; Wallén P
Thromb Res; 1995 Jan; 77(2):149-64. PubMed ID: 7740507
[TBL] [Abstract][Full Text] [Related]
30. Replacement of finger and growth factor domains of tissue plasminogen activator with plasminogen kringle 1. Biochemical and pharmacological characterization of a novel chimera containing a high affinity fibrin-binding domain linked to a heterologous protein.
Langer-Safer PR; Ahern TJ; Angus LB; Barone KM; Brenner MJ; Horgan PG; Morris GE; Stoudemire JB; Timony GA; Larsen GR
J Biol Chem; 1991 Feb; 266(6):3715-23. PubMed ID: 1847387
[TBL] [Abstract][Full Text] [Related]
31. A steady-state template model that describes the kinetics of fibrin-stimulated [Glu1]- and [Lys78]plasminogen activation by native tissue-type plasminogen activator and variants that lack either the finger or kringle-2 domain.
Horrevoets AJ; Pannekoek H; Nesheim ME
J Biol Chem; 1997 Jan; 272(4):2183-91. PubMed ID: 9036151
[TBL] [Abstract][Full Text] [Related]
32. Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site. An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric molecules.
Novokhatny V; Medved L; Lijnen HR; Ingham K
J Biol Chem; 1995 Apr; 270(15):8680-5. PubMed ID: 7721771
[TBL] [Abstract][Full Text] [Related]
33. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
Doolittle RF; Pandi L
Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
[TBL] [Abstract][Full Text] [Related]
34. Kinetics of the activation of plasminogen by natural and recombinant tissue-type plasminogen activator.
Zamarron C; Lijnen HR; Collen D
J Biol Chem; 1984 Feb; 259(4):2080-3. PubMed ID: 6538196
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.
Stewart RJ; Fredenburgh JC; Weitz JI
J Biol Chem; 1998 Jul; 273(29):18292-9. PubMed ID: 9660794
[TBL] [Abstract][Full Text] [Related]
36. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
Rydzewski A; Castellino FJ
Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
[TBL] [Abstract][Full Text] [Related]
37. Vampire bat salivary plasminogen activator exhibits a strict and fastidious requirement for polymeric fibrin as its cofactor, unlike human tissue-type plasminogen activator. A kinetic analysis.
Bergum PW; Gardell SJ
J Biol Chem; 1992 Sep; 267(25):17726-31. PubMed ID: 1387641
[TBL] [Abstract][Full Text] [Related]
38. Influence of various structural domains of fibrinogen and fibrin on the potentiation of plasminogen activation by recombinant tissue plasminogen activator.
de Serrano VS; Urano T; Gaffney PJ; Castellino FJ
J Protein Chem; 1989 Feb; 8(1):61-77. PubMed ID: 2527513
[TBL] [Abstract][Full Text] [Related]
39. The structure basis of the poor fibrin specificity of urokinase (II)--The inhibition of urokinase A chain 149-157 on the fibrin stimulated activation of plasminogen by tissue type plasminogen activator.
Song A; Liu JN; Yu RR; Cui DF; Zhou TM; Cui HR; Zhu DX
Sci China B; 1992 Aug; 35(8):966-73. PubMed ID: 1338753
[TBL] [Abstract][Full Text] [Related]
40. On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid.
van Zonneveld AJ; Veerman H; Pannekoek H
J Biol Chem; 1986 Oct; 261(30):14214-8. PubMed ID: 3021732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
